Marinus Pharmaceuticals, Inc. (MRNS)
NASDAQ: MRNS · Real-Time Price · USD
1.565
+0.015 (0.97%)
Sep 18, 2024, 3:14 PM EDT - Market open

Marinus Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
30.2630.9925.4815.351.72-
Upgrade
Revenue Growth (YoY)
16.56%21.63%66.03%793.19%--
Upgrade
Cost of Revenue
97.43101.3281.427550.5142.27
Upgrade
Gross Profit
-67.16-70.33-55.94-59.65-48.79-42.27
Upgrade
Selling, General & Admin
65.5661.1556.8537.2819.1512.16
Upgrade
Research & Development
0.47-----
Upgrade
Operating Expenses
66.0361.1556.8537.2819.1512.16
Upgrade
Operating Income
-133.19-131.49-112.79-96.93-67.94-54.42
Upgrade
Interest Expense
-17.5-16.9-10.67-2.58--
Upgrade
Interest & Investment Income
6.218.112.350.080.50.35
Upgrade
Other Non Operating Income (Expenses)
1.251.39-1.870.9-0.04-0.05
Upgrade
EBT Excluding Unusual Items
-143.23-138.88-122.97-98.53-67.48-54.12
Upgrade
Gain (Loss) on Sale of Assets
-4-4107.38---
Upgrade
Asset Writedown
-0.06-0.06-0.83-0.24--
Upgrade
Pretax Income
-149.24-142.94-16.43-98.78-67.48-54.12
Upgrade
Income Tax Expense
--1.543.39---
Upgrade
Net Income
-149.24-141.41-19.82-98.78-67.48-54.12
Upgrade
Preferred Dividends & Other Adjustments
----8.88-
Upgrade
Net Income to Common
-149.24-141.41-19.82-98.78-76.36-54.12
Upgrade
Shares Outstanding (Basic)
565439372714
Upgrade
Shares Outstanding (Diluted)
565439372714
Upgrade
Shares Change (YoY)
20.37%37.56%6.47%34.57%100.10%33.30%
Upgrade
EPS (Basic)
-2.66-2.63-0.51-2.69-2.80-3.97
Upgrade
EPS (Diluted)
-2.66-2.63-0.51-2.69-2.80-3.97
Upgrade
Free Cash Flow
-120.62-118.12-114.66-58.37-60.91-49.02
Upgrade
Free Cash Flow Per Share
-2.15-2.20-2.93-1.59-2.23-3.60
Upgrade
Gross Margin
-221.93%-226.96%-219.57%---
Upgrade
Operating Margin
-440.11%-424.30%-442.69%-631.68%-3954.42%-
Upgrade
Profit Margin
-493.14%-456.31%-77.78%-643.70%-4444.41%-
Upgrade
Free Cash Flow Margin
-398.59%-381.17%-450.04%-380.36%-3545.52%-
Upgrade
EBITDA
-128.66-126.13-111.41-96.58-67.6-54.14
Upgrade
D&A For EBITDA
4.535.361.370.360.330.28
Upgrade
EBIT
-133.19-131.49-112.79-96.93-67.94-54.42
Upgrade
Revenue as Reported
30.2630.9925.4815.351.72-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.